Press

Latest Press Articles

    Jan 10, 2024

    Sanguine Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research

    Comprehensive and real-time electronic health records shorten study timelines and offer new product opportunities

    Nov 01, 2023

    Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth

    Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.

    Sep 26, 2023

    Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles

    Sep 13, 2023

    Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Trans...

    Jan 09, 2023

    Sanguine Biosciences Partners with Broadoak Capital Partners to Accelerate Launch of Ne...

    Aug 11, 2022

    Fortune Best Small Workplaces – #30 out of 100 in the US

    Apr 16, 2021

    PODCAST: The Bio Report: Bringing the Trial to the Patient

    Apr 04, 2021

    Recovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research
email

Subscribe to our Newsletter

Select what you would like to receive directly in your email